To the Editor,
We read with interest both the article published by Aguirre et al. regarding the comparison of intrathecal 2% hyperbaric prilocaine with ropivacaine for patients undergoing knee arthroscopy 1 and the following discussion of Manassero et al. 2 We believe that this exchange of opinions highlights the importance of administering doses of local anesthetics tailored to a particular clinical setting.
The increasing volume of ambulatory surgery has recently led to more research on short-acting and intermediate-acting local anesthetics. Clinicians can now choose between anesthetics to fine-tune spinal anesthesia according to the length of the surgery. In regard to this concept, the dose of spinally administered hyperbaric prilocaine must be precisely defined. Some studies have compared various arbitrarily chosen doses of prilocaine with other local anesthetics in various clinical settings without always taking into account the equipotent doses of these anesthetics. On the contrary, decreasing the dose of hyperbaric prilocaine shortens the duration of the sensory and motor blocks but may lead to block failure depending on the desired sensory block level. 4 In our previously published study, we determined the effective doses (ED 50 and ED 90 ) of intrathecal hyperbaric prilocaine for patients undergoing ambulatory knee arthroscopy. 5 The minimum effective dose for patients undergoing knee arthroscopy (ED 50 ) of hyperbaric 2% prilocaine was 28.9 mg, whereas the ED 90 was 38.5 mg. In our study, all patients met the discharge criteria after 205 min and could spontaneously urinate.
Moreover, the regression model we employed for statistical analysis suggested that 50 mg was the optimal clinical dose for knee arthroscopy. Indeed, with doses \50 mg, the patient could be exposed to block failure. Larger doses provided no gain in terms of successful spinal anesthesia and increased the side effects. 4 The comparison of local anesthetics in particular clinical settings should be performed using equipotent doses. Thus, for some of the earlier local anesthetics with a new formulation (e.g., hyperbaric prilocaine and chloroprocaine), ED 90 must be known and used.
